Sector Gamma AS Lowers Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Sector Gamma AS decreased its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 37.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 164,305 shares of the company's stock after selling 99,831 shares during the quarter. Cardinal Health comprises approximately 4.0% of Sector Gamma AS's investment portfolio, making the stock its 10th largest holding. Sector Gamma AS owned about 0.07% of Cardinal Health worth $16,562,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Aaron Wealth Advisors LLC grew its position in shares of Cardinal Health by 1.2% during the 4th quarter. Aaron Wealth Advisors LLC now owns 8,369 shares of the company's stock worth $844,000 after buying an additional 97 shares during the period. Schechter Investment Advisors LLC lifted its holdings in shares of Cardinal Health by 4.1% in the 4th quarter. Schechter Investment Advisors LLC now owns 2,480 shares of the company's stock worth $250,000 after purchasing an additional 98 shares in the last quarter. Cypress Capital Group lifted its holdings in shares of Cardinal Health by 0.7% in the 3rd quarter. Cypress Capital Group now owns 17,133 shares of the company's stock worth $1,487,000 after purchasing an additional 111 shares in the last quarter. Monument Capital Management lifted its holdings in shares of Cardinal Health by 3.0% in the 3rd quarter. Monument Capital Management now owns 4,639 shares of the company's stock worth $403,000 after purchasing an additional 136 shares in the last quarter. Finally, Guardian Wealth Advisors LLC lifted its holdings in shares of Cardinal Health by 1.7% in the 3rd quarter. Guardian Wealth Advisors LLC now owns 8,318 shares of the company's stock worth $722,000 after purchasing an additional 140 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

Wall Street Analysts Forecast Growth

CAH has been the topic of a number of recent research reports. Barclays initiated coverage on Cardinal Health in a report on Wednesday, January 3rd. They issued an "overweight" rating and a $117.00 target price on the stock. SVB Leerink initiated coverage on Cardinal Health in a report on Monday, February 26th. They issued an "outperform" rating and a $125.00 target price on the stock. UBS Group increased their target price on Cardinal Health from $122.00 to $125.00 and gave the stock a "buy" rating in a report on Monday, February 5th. Argus upgraded Cardinal Health from a "hold" rating to a "buy" rating in a report on Friday, February 9th. Finally, Leerink Partnrs restated an "outperform" rating on shares of Cardinal Health in a research note on Monday, February 26th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $103.07.

Cardinal Health Price Performance

Shares of Cardinal Health stock traded down $0.60 during trading hours on Friday, hitting $103.21. 1,399,916 shares of the company's stock traded hands, compared to its average volume of 1,705,735. Cardinal Health, Inc. has a 12-month low of $77.56 and a 12-month high of $116.04. The stock has a market capitalization of $25.10 billion, a price-to-earnings ratio of 40.63, a PEG ratio of 1.05 and a beta of 0.68. The company has a fifty day simple moving average of $109.51 and a 200-day simple moving average of $104.76.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Thursday, February 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.56 by $0.26. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. The firm had revenue of $57.45 billion during the quarter, compared to analyst estimates of $57.02 billion. During the same period last year, the firm posted $1.32 EPS. The business's revenue was up 11.6% compared to the same quarter last year. On average, analysts forecast that Cardinal Health, Inc. will post 7.28 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were given a dividend of $0.5006 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.94%. The ex-dividend date of this dividend was Thursday, March 28th. Cardinal Health's dividend payout ratio is presently 78.74%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.